Literature DB >> 8863847

Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.

S M Yu1, S F Chen, Y T Lau, C M Yang, J C Chen.   

Abstract

The mitogenic effect of extracellular ATP was examined in cultured rat aortic smooth muscle cells (VSMCs). ATP, 2-methylthio-ATP, and ADP stimulated [3H]thymidine and [3H]leucine incorporation and cell growth. AMP, adenosine, UTP, and P2x agonists showed little of these effects. Reactive blue 2, a P2Y purinoceptor antagonist, was effective in suppressing the mitogenic effect of ATP and 2-methylthio-ATP, indicating that extracellular ATP-induced VSMC proliferation is mediated by P2Y purinoceptors. The P2Y purinoceptor activation was coupled to a pertussis toxin (PTX)-insensitive G protein (Gq) and triggered phosphoinositide hydrolysis with subsequent activation of protein kinase C (PKC), Raf-1, and mitogen-activated protein kinase (MAPK) in VSMCs. In response to ATP, both 42-and 44-kDa MAPKs were activated, and tyrosine was phosphorylated. Western blot analysis using PKC isozyme-specific antibodies indicated that VSMCs express PKC-alpha, PKC-delta, and PKC-zeta. A complete down-regulation of PKC-alpha and PKC-delta was seen after 24-hr treatment with 12-O-tetradecanoylphorbol-13-acetate. When cells were pretreated with 12-O-tetradecanoyl-phorbol-13-acetate for 24 hr and subsequently challenged with ATP, Raf-1 activation and 42-kDa as well as 44-kDa MAPK tyrosine phosphorylation failed to be induced. These results demonstrate that ATP-induced Raf-1 and MAPK activations involve the activation of PKC-alpha and PKC-delta. P2Y purinoceptor stimulation with ATP also caused accumulation of c-fos and c-myc mRNAs. Both Reactive blue 2 and staurosporine significantly blocked this increase by ATP. In conclusion, the mitogenic effect of ATP seemed to be triggered by activation of the Gq protein-coupled P2Y purinoceptor that led to the formation of inositol trisphosphate and activation of PKC. PKC and, in turn, Raf-1 and MAPK were then activated, leading eventually to DNA synthesis and cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863847

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Protein kinase C expression and subcellular distribution in chronic myocardial ischemia. Comparison of two different canine models.

Authors:  M Matejovicova; B Shivalkar; J Vanhaecke; M Szilard; W Flameng
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

Review 2.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

3.  Effect of near-infrared light on in vitro cellular ATP production of osteoblasts and fibroblasts and on fracture healing with intramedullary fixation.

Authors:  Brendan J Quirk; Kumar Sannagowdara; Ellen V Buchmann; Eric S Jensen; David C Gregg; Harry T Whelan
Journal:  J Clin Orthop Trauma       Date:  2016-03-10

4.  Extracellular Nucleotides Can Induce Chemokine (C-C motif) Ligand 2 Expression in Human Vascular Smooth Muscle Cells.

Authors:  Jeung-Il Kim; Hye-Young Kim; Sun-Mi Kim; Sae-A Lee; Yong-Hae Son; Seong-Kug Eo; Byung-Yong Rhim; Koanhoi Kim
Journal:  Korean J Physiol Pharmacol       Date:  2011-02-28       Impact factor: 2.016

5.  Osmotic cell swelling-induced ATP release mediates the activation of extracellular signal-regulated protein kinase (Erk)-1/2 but not the activation of osmo-sensitive anion channels.

Authors:  T Van der Wijk; H R De Jonge; B C Tilly
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

6.  P(2Y) purinoceptor subtypes recruit different mek activators in astrocytes.

Authors:  G Lenz; C Gottfried; Z Luo; J Avruch; R Rodnight; W J Nie; Y Kang; J T Neary
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.